Platelet Aggregation InhibitorsPlatelet AggregationCrotalid VenomsSalivary Proteins and PeptidesDisintegrinsSalivary GlandsBlood PlateletsMolecular Sequence DataAmino Acid SequenceCongo RedPlatelet AdhesivenessPlatelet CountAmyloid beta-PeptidesPlatelet Membrane GlycoproteinsAdenosine DiphosphatePeptide FragmentsPlatelet Function TestsPlatelet Glycoprotein GPIIb-IIIa ComplexBleeding TimeThrombinCell AggregationPeptidesFibrinogenThromboxane A2Platelet ActivationPlatelet Factor 4Platelet Activating FactorPlatelet Glycoprotein GPIb-IX ComplexAspirinCollagenThrombosisReceptors, Purinergic P2Y12Thromboxane B2Platelet TransfusionRistocetinApyrasevon Willebrand FactorP-SelectinSerotoninBlood CoagulationEpoprostenolThromboxanesBlood Platelet DisordersThrombocytopeniaDose-Response Relationship, DrugAntigens, Human Platelet15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidErythrocyte AggregationHemostasisProstaglandin Endoperoxides, SyntheticEpinephrineTiclopidineThrombastheniaPlatelet Factor 3Platelet Membrane Glycoprotein IIbAntihypertensive AgentsMegakaryocytesImmunoglobulin Fab FragmentsFormularies as TopicDrug Utilization ReviewRabbitsReceptors, ThromboxaneArachidonic AcidAntibodies, MonoclonalTime FactorsKineticsCalciumArachidonic AcidsReceptors, ThrombinProtein BindingPrescription DrugsBlood Coagulation FactorsReceptors, Thromboxane A2, Prostaglandin H2HemorheologyOligopeptidesReceptors, Purinergic P2Y1Blood Coagulation TestsPurinergic P2Y Receptor AntagonistsDrug Therapy, CombinationPharmaceutical PreparationsDual Specificity Phosphatase 2Drug PrescriptionsThromboxane-A SynthaseDrug InteractionsPlatelet-Rich PlasmaCarotid Artery ThrombosisHydrazinesHeparin